October 28, 2019
Mirum Pharmaceuticals announces appointment of new Chief Medical Officer
Mirum Pharmaceuticals has appointed Ed Tucker as Chief Medical Officer, the company said Monday.
Pharmaceuticals, Biotechnology and Life Sciences
Mirum Pharmaceuticals has appointed Ed Tucker as Chief Medical Officer, the company said Monday.
AstraZeneca announced Monday that Imfinzi (durvalumab) and IMFINZI Plus Tremelimumab Delayed Disease Progression in Phase III POSEIDON Trial for 1st-Line…
5-Center Study of the Device is Intended to Provide Clinical Data in Support of MedRhythms’ FDA Submission.
LONDON–(BUSINESS WIRE)–#Analytics–Quantzig, a global data analytics and advisory firm, that delivers actionable analytics solutions to resolve complex business problems has…
MCLEAN, Va.–(BUSINESS WIRE)–The Thought Leadership & Innovation Foundation (TLI) announces today plans to build on its existing Regenerative Medicine Program…
WEST CHESTER, Pa.–(BUSINESS WIRE)–Molecular Targeting Technologies, Inc. (MTTI) announced today that the NIBIB (an Institute within the National Institutes of…
– Rolling Submission of the Remaining BLA Sections Continues On Track for Scheduled Completion 1H 2020 – SEATTLE–(BUSINESS WIRE)–Omeros Corporation…
ZW25 Plus Chemotherapy Shows Durable Activity in Patients with Heavily Pretreated Gastroesophageal Adenocarcinoma Data Continue to Support Ongoing Phase 2…
FOSTER CITY, Calif.–(BUSINESS WIRE)–Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a biopharmaceutical company focused on the development and commercialization of novel therapies…
– Posters at AACR-NCI-EORTC and SITC illustrate genome-wide, in vivo T-cell approach to identify and validate novel therapeutic immuno-oncology targets…